Related Experiment Videos
Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA
Natini Jinawath1, Yoichi Furukawa, Suguru Hasegawa
1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Oncogene
|July 27, 2004
Summary
This study investigated diffuse-type gastric cancer, a form with a poorer prognosis. Researchers identified distinct molecular signatures, revealing altered gene expression related to cell-matrix interactions in diffuse-type cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Gastric cancer is a leading cause of cancer death globally.
- Two main types, intestinal and diffuse, have different characteristics and origins.
- Diffuse-type gastric cancer has a poorer prognosis and less understood molecular mechanisms.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying diffuse-type gastric cancer development and progression.
- To compare gene expression profiles between diffuse-type gastric cancer and noncancerous tissues.
- To identify molecular differences between diffuse-type and intestinal-type gastric cancers.
Main Methods:
- Utilized cDNA microarray analysis on 20 laser-microbeam-microdissected diffuse-type gastric cancer tissues and corresponding noncancerous mucosa.
- Analyzed gene expression profiles of 23,040 genes.
- Compared expression profiles between diffuse-type and intestinal-type gastric cancers.
Main Results:
- Identified 153 upregulated and over 1500 downregulated genes in diffuse-type tumors.
- Discovered genes associated with tumor progression.
- Found 46 genes potentially distinguishing diffuse-type from intestinal-type gastric cancers.
- Diffuse-type signature showed altered cell-matrix interaction and extracellular-matrix (ECM) gene expression.
- Intestinal-type signature indicated enhanced cell growth.
Conclusions:
- Provides insights into distinct molecular mechanisms of gastric carcinogenesis for different histological types.
- Suggests potential for identifying novel diagnostic markers for diffuse-type gastric cancer.
- Highlights potential therapeutic targets for diffuse-type gastric cancers based on identified molecular signatures.